Skip to Main Content (Press Enter)

Logo UNIBS
  • ×
  • Home
  • People
  • Organizations
  • Expertise & Skills
  • Outputs
  • Jobs
  • Degrees
  • Courses
  • Third Mission
  • Equipment

Expertise & Skills
Logo UNIBS

|

Expertise & Skills

unibs.it
  • ×
  • Home
  • People
  • Organizations
  • Expertise & Skills
  • Outputs
  • Jobs
  • Degrees
  • Courses
  • Third Mission
  • Equipment
  1. Outputs

Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis

Academic Article
Publication Date:
2017
Abstract:
Minimal residual disease prior to allogeneic hematopoietic cell transplantation has been associated with increased risk of relapse and death in patients with acute myeloid leukemia, but detection methodologies and results vary widely. We performed a systematic review and meta-analysis evaluating the prognostic role of minimal residual disease detected by polymerase chain reaction or multiparametric flow cytometry before transplant. We identified 19 articles published between January 2005 and June 2016 and extracted hazard ratios for leukemia-free survival, overall survival, and cumulative incidences of relapse and non-relapse mortality. Pre-transplant minimal residual disease was associated with worse leukemia-free survival (HR=2.76 [1.90-4.00]), overall survival (HR=2.36 [1.73-3.22]), and cumulative incidence of relapse (HR=3.65 [2.53-5.27]), but not non-relapse mortality (HR=1.12 [0.81-1.55]). These associations held regardless of detection method, conditioning intensity, and patient age. Adverse cytogenetics was not an independent risk factor for death or relapse. There was more heterogeneity among studies using flow cytometry-based than WT1 polymerase chain reaction-based detection (I(2)=75.1% vs. <0.1% for leukemia-free survival, 67.8% vs. <0.1% for overall survival, and 22.1% vs. <0.1% for cumulative incidence of relapse). These results demonstrate a strong relationship between pre-transplant minimal residual disease and post-transplant relapse and survival. Outcome heterogeneity among studies using flow-based methods may underscore site-specific methodological differences or differences in test performance and interpretation.
CRIS type:
1.1 Articolo in rivista
Keywords:
Acute Myeloid Leukemia; Hematopoietic Stem Cell; Minimal Residual Disease
List of contributors:
Buckley, Sarah A; Wood, Brent L; Othus, Megan; Hourigan, Christopher S; Ustun, Celalettin; Linden, Michael A; Defor, Todd E; Malagola, Michele; Anthias, Chloe; Valkova, Veronika; Kanakry, Christopher G; Gruhn, Bernd; Buccisano, Francesco; Devine, Beth; Walter, Roland B.
Authors of the University:
MALAGOLA MICHELE
Handle:
https://iris.unibs.it/handle/11379/487750
Full Text:
https://iris.unibs.it/retrieve/handle/11379/487750/54863/Buckley%20et%20al_Haematol%202017.pdf
Published in:
HAEMATOLOGICA
Journal
  • Support
  • Privacy
  • Use of cookies
  • Legal notes

Powered by VIVO | Designed by Cineca | 26.11.1.0